Prognostic implications of <i>TET2</i> variant allele frequency in chronic myelomonocytic leukemia: a multicenter study. [PDF]
Wang YH +18 more
europepmc +1 more source
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients. [PDF]
Alsugair A +30 more
europepmc +1 more source
Two cases of lysozyme-induced nephropathy with varying underlying diseases: myelodysplastic syndrome and chronic myelomonocytic leukemia. [PDF]
Furukawa H +15 more
europepmc +1 more source
Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study. [PDF]
Short NJ +20 more
europepmc +1 more source
Cumulative incidence and prognostic factors for leukemic transformation in chronic myelomonocytic leukemia: a competing risk analysis. [PDF]
Huang J, Zheng C, Liu Y, Li C, Xin X.
europepmc +1 more source
Dynamic lineage evolution in hematologic malignancies: a case report of B-ALL Progressing to CMML and AML. [PDF]
Abdullah S +5 more
europepmc +1 more source
Ras-associated autoimmune leukoproliferative disorder associated with immune thrombotic thrombocytopenic purpura. [PDF]
Carter MA +6 more
europepmc +1 more source
[Massive splenic infarction in a case of CMML].
OITA, Makoto +6 more
openaire +2 more sources
Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment-Naïve Patient. [PDF]
Sweileh MW +5 more
europepmc +1 more source
Toward eRASing the challenge of CMML heterogeneity
Hasse M. Addinsell, Daniel H. Wiseman
openaire +3 more sources

